Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-01-01 @ 2:19 AM
Study NCT ID:
NCT00006033
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2000-07-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-06
Completion Date Type:
ACTUAL
First Submit Date:
2000-07-05
First Submit QC Date:
None
Study First Post Date:
2004-06-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-29
Last Update Post Date:
2013-05-30
Last Update Post Date Type:
ESTIMATED